Mgen Solutions Co., Ltd. Stock

Equities

A032790

KR7032790008

Electronic Equipment & Parts

End-of-day quote Korea S.E. 18:00:00 2024-05-09 EDT 5-day change 1st Jan Change
1,891 KRW -2.73% Intraday chart for Mgen Solutions Co., Ltd. -3.67% +16.44%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 110B 80.15M 110M Sales 2023 90.53B 66.09M 90.35M Capitalization 51.57B 37.65M 51.47M
Net income 2022 -435M -318K -434K Net income 2023 -21.26B -15.52M -21.22M EV / Sales 2022 0.49 x
Net cash position 2022 13.01B 9.5M 12.99M Net cash position 2023 7.82B 5.71M 7.81M EV / Sales 2023 0.48 x
P/E ratio 2022
-144 x
P/E ratio 2023
-2.43 x
Employees 86
Yield 2022 *
-
Yield 2023
-
Free-Float 82.41%
More Fundamentals * Assessed data
Dynamic Chart
Mgen Solutions Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mgen Solutions Co., Ltd. announced that it has received KRW 3 billion in funding CI
Mgen Solutions Co., Ltd. announced that it expects to receive KRW 3 billion in funding CI
Mgen Solutions Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mgen Solutions to Raise 14.3 Billion Won Through Share Issuance MT
Mgen Solutions Co., Ltd. agreed to acquire the remaining stake in MUSEM VINA COMPANY LIMITED for KRW 5.1 billion CI
Mgen Solutions Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm CI
Mgen Solutions Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mgen Solutions Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mgen Solutions Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bngt Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Bngt Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bngt Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Mgenplus Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Mgenplus Co.,Ltd. announced that it has received KRW 4 billion in funding CI
More news
1 day-2.73%
1 week-3.67%
Current month-3.52%
1 month-20.04%
3 months+33.73%
6 months+17.60%
Current year+16.44%
More quotes
1 week
1 889.00
Extreme 1889
2 025.00
1 month
1 817.00
Extreme 1817
2 460.00
Current year
1 297.00
Extreme 1297
2 570.00
1 year
1 297.00
Extreme 1297
4 195.00
3 years
1 297.00
Extreme 1297
5 700.00
5 years
1 297.00
Extreme 1297
9 650.00
10 years
1 297.00
Extreme 1297
31 050.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 -
Chief Tech/Sci/R&D Officer 46 -
Comptroller/Controller/Auditor 61 -
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 36 -
Director/Board Member 43 -
More insiders
Date Price Change Volume
24-05-10 1,891 -2.73% 232,507
24-05-09 1,944 -1.82% 203,273
24-05-08 1,980 +0.25% 198,526
24-05-07 1,975 +2.76% 322,973
24-05-03 1,922 -2.09% 319,443

End-of-day quote Korea S.E., May 09, 2024

More quotes
Mgen Solutions Co Ltd, formerly BNGT Co Ltd, is a Korea-based company engaged in the manufacture and sale of printer cartridge parts. The Company operates its business through five segments. The Developing Machine Business segment is engaged in the manufacture and sale of printer cartridge parts. The Broadband Convergence Network (BcN)/Artificial Intelligence (AI) Business segment is engaged in the operation and build of broadband self-communication network. The Segment is also engaged in the provision of artificial intelligence image analysis solutions. The Communication Network Business segment is engaged in the provision of information technology services related to smart homes and the Internet of Things (IoT). The Bio Business segment is engaged in the development of organs for transplantation. The Other Business segment is engaged in the sale of medical devices.
More about the company
  1. Stock Market
  2. Equities
  3. A032790 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW